Stocks/HURA

HURA

TuHURA Biosciences, Inc.
Healthcare·Biotechnology
$2.26
$144M market cap
Revenue
$0.0M
Free Cash Flow
$-10.1M
Rev Growth
+0.0%
FCF Margin
0.0%
P/FCF
--
EV/FCF
--
Fwd EV/EBITDA
--
Fair Value
--
Upside
--

TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.

2-Year Price History

$2.50-66.0%
$2.0$4.0$6.0$8.0$10volJun 24Oct 24Jan 25May 25Sep 25Jan 26May 26

Quarterly Financials & Projections

Quarterly Waterfall ($ M)
PeriodRevEBITDAOpInNIOCFFCFCapExCashDebtSharesROICIntCovEV/EBITDA
Act2026-Q10.0-7.5-7.5-7.5-4.4-4.5-0.16.30.560.0-320.0%-268.3x--
Act2025-Q40.0-6.1-8.2-6.8-5.6-5.6-0.03.60.547.9-447.6%-10.1x--

Valuation & Metrics

Market Stats

Price$2.26
Market Cap$144M
Enterprise Value$138M
P/S Ratio0.0x
P/FCF--
EV/FCF--
FCF Margin (TTM)0.0%
FCF Yield-7.0%
Dividend Yield (TTM)--
Annual Dilution0.0%
CurrencyUSD

TTM Financial Snapshot

Revenue$0.0M
Net Income$-14.3M
Free Cash Flow$-10.1M

Revenue Growth (YoY)+0.0%
EBITDA Margin0.0%
Net Margin0.0%
FCF Margin0.0%
CapEx % of Revenue0.0%
SBC % of Revenue0.0%
ROIC-383.8%
WC Change % Rev0.0%
Interest Coverage-21.4x

Forward Outlook & Risk

Short Interest

Short % of Float--
Short Shares8.3M
Days to Cover7.8
Change (vs Prior)-0.7%
Need at least 2 settlement dates for chart

Employees

Headcount19
Revenue / Employee$0
Gross Profit / Employee$-1,235

Cash Runway

7.5months
CRITICAL

Institutional Ownership

Headline & net flow

NEUTRAL
Net flow · still filing
No float data — flow unavailable.

Ownership composition

Active
3.1%(+0.9% YoY)
76 filers
hedge / family / endowment
Retail funds
Fidelity, Schwab, 401(k)
Passive
8.3%(+2.6% YoY)
8 filers
Vanguard, iShares, SPDR
Market makers
0.1%(-0.0% YoY)
3 filers
Citadel, Susquehanna
Insiders
Form 4 — latest per insider
0%25%50%75%100%2024-122025-032025-062025-092025-122026-03
ActiveRetail fundsPassiveMarket makersRetail direct

Top holders

Fund$ valueCost basisΔ QoQΔ YoYα lifeFund AUM
BlackRock, Inc.Passive$4.4M$2.36+$1.6M+$3.7M-0.2%$5.69T
VANGUARD CAPITAL MANAGEMENT LLCPassive$3.7M$1.79+$3.7M+$3.7M$4.04T
GEODE CAPITAL MANAGEMENT, LLCPassive$1.8M$2.55+$581K+$1.3M+2.3%$1.61T
AQR CAPITAL MANAGEMENT LLC$1.1M$1.83+$1.1M+$1.1M-0.2%$218.19B
STATE STREET CORPPassive$918K$2.12+$401K+$863K-0.2%$2.89T
NORTHERN TRUST CORPPassive$534K$2.40+$191K+$431K-0.2%$755.34B
VANGUARD FIDUCIARY TRUST COPassive$514K$1.79+$514K+$514K$395.83B
VANGUARD PORTFOLIO MANAGEMENT LLCPassive$454K$1.79+$454K+$454K$1.91T
Bank of New York Mellon Corp$379K$2.16+$2K+$379K-0.2%$543.21B
Apollon Wealth Management, LLC$283K$3.25+$42K+$77K-1.6%$6.12B
Cetera Investment Advisers$251K$1.79+$251K+$251K-0.2%$93.23B
Suncoast Equity Management$187K$4.01+$0+$8K+2.0%$833M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC$177K$2.39+$30K+$150K+0.7%$645.81B
WealthShield Partners, LLC$164K$1.79+$164K+$164K+0.3%$897M
IEQ CAPITAL, LLC$146K$1.79+$146K+$146K-0.9%$21.54B
BANK OF AMERICA CORP /DE/$140K$1.59+$27K+$106K-0.1%$1.36T
DEUTSCHE BANK AG\$129K$1.23−$14K+$129K-0.3%$302.17B
GOLDMAN SACHS GROUP INC$126K$1.21+$56K+$126K-0.2%$760.93B
GSA CAPITAL PARTNERS LLP$112K$1.79+$112K+$112K-5.9%$1.61B
UBS Group AG$111K$2.84+$61K−$90K-0.3%$562.11B
Cost basis is a volume-weighted estimate from accumulation periods within our 13F history; holders who built their position before our window started will show a stale basis. % above the cost basis is the unrealized gain at the current price.

Trading behavior

Smart-money alpha (lifetime, %/qtr)NEUTRAL
Holders
-0.26%
avg per quarter
Holders (ex-self)
-0.26%
excl. this stock
Buyers (this Q)
-0.41%
63 buyers · $0.01B in
Sellers (this Q)
-0.84%
12 sellers · $0.00B out
alpha coverage: 72% of $ has a lifetime-alpha record
Holder behavior on this stocksource: stock
On big dips (−10%+)
+10.1%
how holders react when this stock falls
On quiet Qs
-0.5%
−10% to +10% baseline
On rallies (+10%+)
+11.0%
how they react when this stock rises
Holders' portfolio flow this Q
+3.1%
inflows — adds are organic
Sellers' portfolio flow this Q
+12.5%
Sellers grew AUM elsewhere — opinionated cut of this stock.
▸ Compare to holder-profile behavior (across all their stocks)
Holder dip (any stock)
+0.6%
Holder mid (any stock)
-0.5%
Holder rally (any stock)
-1.7%

Top Holders Over Time

5-year share-count history (top 10 holders by peak, incl. exited) + price

0346K692K1.0M1.4M$0.76$1.59$2.42$3.26$4.092024-122025-032025-062025-092025-122026-03
hover the chart for per-quarter detailprice (right axis)
FIFTH THIRD BANCORPAQR CAPITAL MANAGEMENT LLC607KUBS Group AG62KBank of New York Mellon Corp212KSuncoast Equity Management104KApollon Wealth Management, LLC158KCITIGROUP INC2KCetera Investment Advisers140KSquarepoint Ops LLCCHARLES SCHWAB INVESTMENT MANAGEMENT INC99K

Analyst Coverage

Analyst Coverage
Analyst Ratings
2
Buy: 2Consensus: Buy

Corporate

Order Flow (FINRA, ~3w lag)

44.8%retail-1.6pp
9.1%dark+2.5pp
week of 2026-04-13
0%10%20%30%40%50%60%24-1125-0225-0525-0825-1126-0226-04retail (non-ATS)dark (ATS)
Off-exchange volume from FINRA. Retail = non-ATS (wholesaler PFOF + broker internalization). Dark = ATS (dark-pool crossing networks, institutional). Lit-exchange = remainder.